Sudden unexpected death in epilepsy (SUDEP) is the leading cause of epilepsy-related deaths in children and adults with ...

PEDS trial shows tirzepatide delivers durable glycemic control and weight benefit in youth with type 2 diabetes, the first therapy to show this effect.

In the field of health, the development of artificial intelligence (AI) may mean major breakthroughs in personalizing ...

Mass shootings, political violence and school safety are front of mind for many Americans following a recent spate of ...

Good afternoon and happy Thursday, readers! Permitting reform continued to dominate discussions at National Clean Energy Week here ...

Researchers have found bariatric surgery to be more cost-effective for treating patients with obesity compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to new study ...

Tirzepatide was associated with significant declines in HbA1c and BMI for children and adolescents with type 2 diabetes, according to data from the SURPASS-PEDS trial. Tamara S. Hannon, MD, professor ...

The SURPASS-PEDS trial was a randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of tirzepatide in children and adolescents aged 10 to less than 18 years old with T2D ...

In the most comprehensive look yet at whether people are using Gov. Gavin Newsom’s CARE Court, we found that far fewer Californians are enrolled.

Findings indicate that while outdoor walking reduces frailty in older adults, maintaining these gains necessitates continuous ...

Lower HCRU and costs may be reflective of improved patient care.

Health Secretary Robert F. Kennedy, Jr. chose everyone in the group. Their votes could affect vaccine access for certain ...